EBD Group is part of the KNect365 of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Partnerships in Cell and Gene Therapy Partnerships in Cell and Gene Therapy Partnerships in Cell and Gene Therapy Partnerships in Cell and Gene Therapy
Share/Follow Us
Share this:
Follow this event:
Subscribe to our newsletters:

Partnerships in Cell and Gene Therapies Press Releases

partnering360:Insight Latest headlines from partnering360:Insight

September 21, 2017 Landmark Angels focuses on funding emerging and early stage biotech Angel investing plays an important part in the biotech ecosystem, providing much needed early stage capital to startups. One of the more recognizable players in the angel investing sector is Landmark Angels based in Greenwich, Connecticut. more ►

August 21, 2017 Interview: The Michael J. Fox Foundation for Parkinson’s Research Non-dilutive funding sources are available if you know where to look. Building relationships with key contacts from government agencies, foundations, and other organizations can provide valuable investments and insights to move research projects forward. Sohini Chowdhury, Deputy CEO of The Michael J. Fox Foundation for Parkinson’s Research, shares her insights on how companies can tap into her organization's capabilities and resources. more ►

August 21, 2017 Virtual Reality poised to transform mental health therapy Mental health applications of virtual reality are transforming what’s possible in mental health therapy. Because this technology, popular among gamers, is immersive, it allows mental health therapists to place patients into customized worlds within the safety of their offices, from which they may learn to manage anxiety disorders, psychoses, ADHD, pain and other mental and behavioral conditions. more ►

August 17, 2017 ClearView: Should you partner or go it alone? Partnering isn’t an all-or-nothing, one-size-fits-all commercialization plan. There are a multitude of options and strategies, including the option of choosing not to partner. To decide which is best for your company and your assets, evaluate your options early and in detail. more ►

August 17, 2017 Merck values innovation…in deals and ideas The key to getting Merck’s attention is to have a highly differentiated product that makes a substantial difference in patients’ lives. Having clinical data helps, but isn’t strictly necessary. The specific therapeutic area is less important than having a novel solution that solves real problems. more ►

Arrow Up

Follow this event:
Home | Contact Us | Site Map
See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2016 EBD Group
Privacy Policy and Cookies
Terms of Use